ClinicalTrials.Veeva

Menu

Stress and Neurofeedback in Anorexia Nervosa

University of California San Diego logo

University of California San Diego

Status

Terminated

Conditions

Atypical Anorexia Nervosa
Anorexia Nervosa

Treatments

Behavioral: Negative Affect Task

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Anorexia nervosa (AN) and atypical AN (AAN) are severe psychiatric illnesses associated with high disease burden including high treatment costs and excessive mortality rates. Primary characteristics of AN and AAN are food restriction, associated fear of weight gain, and a disturbance in how one's body weight or shape is experienced.The underlying neural mechanisms for the core illness behaviors of food restriction and body size overestimation in anorexia nervosa and atypical anorexia nervosa are not well understood.

This project will use neurofeedback and advanced psychophysical methods to assess and moderate the neural and behavioral responses to stress and relate those results to the naturalistic environment. The results will guide the development of novel interventions.

Full description

The overall strategy is a cross-sectional study, involving 3 subject groups, each subject studied on two study days (one negative and one neutral affect day, randomized), one week apart; on both study days subjects will undergo functional magnetic resonance imaging (fMRI) during which they complete tasks for 1) neurofeedback-reward learning and 2) body size estimation. Before and after each scan, and in the week between scans, subjects will be assessed for positive and negative affect and how it affects food intake.

Enrollment

2 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy Controls (HC)

  • Individuals aged 18-45 years
  • Healthy body weight between 90 and 110 % average body weight since puberty.
  • Regular monthly menstrual cycle (if applicable)
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • English is primary language spoken

Anorexia Nervosa (AN)

  • Age 18-45 years old
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • Current diagnosis of anorexia nervosa, including being underweight, will have a severe fear of weight gain, body image distortion and absence of the menstrual cycle over three consecutive months.
  • English is primary language spoken

Atypical Anorexia Nervosa (AAN)

  • Age 18-45 years old
  • Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200
  • All ethnic backgrounds
  • Meets the criteria for anorexia nervosa except despite significant weight loss, the individual's weight is within or above the normal range
  • English is primary language spoken

Exclusion criteria

Healthy Controls (HC)

  • Current pregnancy or breast feeding within last 3 months
  • First degree relative with current or past eating disorder
  • Psychiatric Medication use such as selective serotonin reuptake inhibitors (SSRIs), atypical antipsychotics, etc.
  • Past or present Axis I psychiatric disorder including substance or alcohol use disorder as determined through structured clinical interview
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Major Medical illness that requires medication or have significant impact on subject's life such as: diabetes, Alzheimer's disease or dementia, stroke, learning disability, mobility disorders, cancer, high blood pressure, etc. (to be determined through biological screening form and interview with principal investigator (PI)
  • Recent history of suspected substance abuse or a lifetime history of psychostimulant abuse and/or dependence
  • Contraindications to magnetic resonance imaging (MRI) including metal implants or braces (as determined through fMRI screening form)

Anorexia Nervosa (AN)

  • Pregnancy or breast feeding within last 3 months
  • Lifetime history of bipolar I disorder or psychosis
  • Current substance abuse or dependence in the past 3 months
  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Electrolyte, blood count or kidney or liver function abnormalities
  • Contraindications to MRI including metal implants or braces (as determined through fMRI screening form)

Atypical Anorexia Nervosa (AAN)

  • Pregnancy or breast feeding within last 3 months
  • Lifetime history of bipolar disorder or psychosis
  • Current substance abuse or dependence in the past 3 months
  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Electrolyte, blood count or kidney or liver function abnormalities
  • Contraindications to MRI including metal implants or braces (as determined through fMRI screening form)

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

2 participants in 1 patient group

Behavioral
Experimental group
Description:
Negative Affect Task
Treatment:
Behavioral: Negative Affect Task

Trial contacts and locations

1

Loading...

Central trial contact

Guido Frank, MD; Megan Shott, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems